首页 / 产品中心 / 单克隆抗体 /

货号: YP-Ab-14218
促销价:

产品介绍

反应种属
Human
应用范围
WB;IP
抗体类型
单克隆抗体
基因名称(Gene Name)
btk
蛋白名称
分子量(DA)
77kD
免疫原
Purified recombinant human BTK protein fragments expressed in E.coli.
特异性
This antibody detects endogenous levels of BTK and does not cross-react with related proteins.
组成
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
来源
Monoclonal, Mouse
稀释比例
wb 1:1000
纯化工艺
The antibody was affinity-purified from mouse ascites by affinity-chromatography using epitope-specific immunogen.
浓度
1 mg/ml
储存
-20°C/1 year
其他名称
Agammaglobulinaemia tyrosine kinase;AGMX 1;AGMX1;AT;ATK;B cell progenitor kinase;B-cell progenitor kinase;BPK;Bruton agammaglobulinemia tyrosine kinase;Bruton tyrosine kinase;Bruton’s Tyrosine Kinase;Btk;BTK_HUMAN;IMD 1;IMD1;MGC126261;MGC126262;OTTHUMP00000063593;PSCTK 1;PSCTK1;Tyrosine protein kinase BTK;Tyrosine-protein kinase BTK;XLA
背景
The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013],
功能
catalytic activity:ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.,cofactor:Binds 1 zinc ion per subunit.,disease:Defects in BTK are the cause of X-linked agammaglobulinemia (XLA) [MIM:300755]; also called X-linked agammaglobulinemia type 1 (AGMX1) or immunodeficiency type 1 (IMD1). XLA is a humoral immunodeficiency disease which results in developmental defects in the maturation pathway of B-cells. Affected boys have normal levels of pre-B-cells in their bone marrow but virtually no circulating mature B-lymphocytes. This results in a lack of immunoglobulins of all classes and leads to recurrent bacterial infections like otitis, conjunctivitis, dermatitis, sinusitis in the first few years of life, or even some patients present overwhelming sepsis or meningitis, resulting in death in a few hours. Treatment in most cases is by infusion of intravenous immunoglobulin.,

展开

产品详情

客户数据及评论 (0)

折叠内容

文献引用

折叠内容

实验方案

折叠内容
>